Detecting and correcting for bias in Mendelian randomization analyses using gene-by-environment interactions by Spiller, Wes et al.
                          Spiller, W., Slichter, D., Bowden, J., & Davey Smith, G. (2018). Detecting
and correcting for bias in Mendelian randomization analyses using gene-by-
environment interactions. International Journal of Epidemiology.
https://doi.org/10.1093/ije/dyy204
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1093/ije/dyy204
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Oxford Academic
at https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyy204/5193695 . Please refer to any applicable
terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
Original article
Detecting and correcting for bias in Mendelian
randomization analyses using Gene-by-
Environment interactions
Wes Spiller,1* David Slichter,2 Jack Bowden1† and
George Davey Smith1†
1Population Health Sciences, University of Bristol, Bristol, UK and 2Department of Economics,
Binghamton University, State University of New York, Binghamton, NY, USA
*Corresponding author. MRC Integrative Epidemiology Unit University of Bristol, Oakfield House, Oakfield Grove, Bristol
BS8 2BN, UK. E-mail: wes.spiller@bristol.ac.uk
†These authors contributed equally to this work.
Editorial decision 23 August 2018; Accepted 17 September 2018
Abstract
Background: Mendelian randomization (MR) has developed into an established method
for strengthening causal inference and estimating causal effects, largely due to the prolif-
eration of genome-wide association studies. However, genetic instruments remain con-
troversial, as horizontal pleiotropic effects can introduce bias into causal estimates.
Recent work has highlighted the potential of gene–environment interactions in detecting
and correcting for pleiotropic bias in MR analyses.
Methods: We introduce MR using Gene-by-Environment interactions (MRGxE) as a
framework capable of identifying and correcting for pleiotropic bias. If an instrument–co-
variate interaction induces variation in the association between a genetic instrument and
exposure, it is possible to identify and correct for pleiotropic effects. The interpretation of
MRGxE is similar to conventional summary MR approaches, with a particular advantage
of MRGxE being the ability to assess the validity of an individual instrument.
Results: We investigate the effect of adiposity, measured using body mass index (BMI),
upon systolic blood pressure (SBP) using data from the UK Biobank and a single weighted al-
lelic score informed by data from the GIANT consortium. We find MRGxE produces findings
in agreement with two-sample summary MR approaches. Further, we perform simulations
highlighting the utility of the approach even when the MRGxE assumptions are violated.
Conclusions: By utilizing instrument–covariate interactions in MR analyses implemented
within a linear-regression framework, it is possible to identify and correct for horizontal
pleiotropic bias, provided the average magnitude of pleiotropy is constant across
interaction-covariate subgroups.
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Introduction
Mendelian randomization (MR) has developed into a mul-
tifaceted approach to assessing causal relationships in epi-
demiology.1,2 In many cases, MR analyses employ genetic
variants as instrumental variables (IVs), allowing consis-
tent estimation of causal effects in the presence of unmeas-
ured confounding. This requires candidate variants to be
associated with the exposure of interest (IV1), to be inde-
pendent of confounders of the exposure and outcome (IV2)
and to be independent of the outcome outside of the medi-
ating effects of the exposure (IV3).3 An instrument satisfy-
ing these assumptions is considered valid, although IV2
and IV3 cannot directly tested.
Pleiotropy plays a central role in MR analyses and can
be subcategorized into vertical and horizontal forms.
Vertical pleiotropy exists in cases where a single genetic
variant influences a phenotype, which in turn influences
another.4 This is the primary mechanism underpinning the
utility of MR in causal-effect estimation. However, a par-
ticular concern when applying MR is horizontal pleiot-
ropy—occurring when a genetic variant is associated with
a study outcome through biological pathways additional to
the exposure of interest.2,5 This violates assumption IV3,
introducing bias into effect estimates in the direction of the
horizontal pleiotropic (henceforth, pleiotropic) effect.5,6
Where multiple instruments are available, one strategy is
to combine causal estimates using each individual variant
in turn within a meta-analysis framework. Provided the ge-
netic variants are uncorrelated, an inverse-variance-
weighted (IVW) estimate will be equivalent to two-stage
least-squares (TSLS) regression and, where pleiotropy is
suspected, MR-Egger, median and modal regression can be
adopted as sensitivity analyses.4,5,7,8
In the single instrument setting, Slichter regression has
emerged from the econometrics literature as a method for
evaluating instrument validity within a potential outcomes
framework.9,10 This involves observing or extrapolating to
a population subgroup for which the instrument and expo-
sure are independent (defined as a no-relevance group) and
measuring the corresponding association between the in-
strument and outcome. The instrument–outcome associa-
tion for a no-relevance group provides an estimate of
pleiotropic effect and allows bias correction within a statis-
tical model. Slichter regression builds upon several key
developments in econometrics, in particular the identifica-
tion and estimation of local average treatment effects put
forward by Imbens and Angrist,10 and the works of
Card,11 Conley et al.12 and Small.13
In this paper, we introduce Slichter regression within
the context of epidemiology, formalizing the increasing use
of gene–environment interactions in assessing instrument
validity.14–20 We present MR using Gene-by-Environment
interactions (MRGxE) as a statistical framework and sensi-
tivity analysis to identify and correct for pleiotropic bias
in MR studies using gene–covariate interactions.
Importantly, MRGxE can assess the validity of a single in-
strument, in contrast to methods examining heterogeneity
across a set of MR estimates using many instruments, and
is not reliant upon the existence of an observed no-rele-
vance group. This represents an improvement upon similar
methods such as Pleiotropy Robust Mendelian
Randomization (PRMR) that, while sharing a similar intui-
tive framework, are reliant upon the existence of an actual
no-relevance group being observed within the data, se-
verely limiting the applicability of the approach.21
Two features differentiate MRGxE from analogous
methods in the econometrics literature. First, MRGxE
adopts a linear-regression framework as opposed to utiliz-
ing local linear regression, improving the ease with which
MRGxE can be implemented. Additionally, MRGxE can
be applied using both individual- and summary-level data.
Such data could be obtained from previously published
studies where subgroup-specific estimates are provided or
alternatively requested from consortia.
To illustrate the utility of MRGxE, we present an applied
example examining the effect of body mass index (BMI) upon
systolic blood pressure (SBP), utilizing data from the GIANT
consortium and the full release of the UK Biobank (July
Key Messages
• Instrument–covariate interactions can be used to identify bias due to horizontal pleiotropy in Mendelian randomization
(MR) analyses, provided they induce sufficient variation in the association between the genetic instrument and exposure.
• By regressing the gene–outcome association upon the gene-exposure association across interaction-covariate sub-
groups, MR using Gene-by-Environment interactions (MRGxE) returns estimates of the average pleiotropic effect and
the pleiotropy adjusted causal effect.
• The interpretation of MRGxE is analogous to that of MR-Egger regression.
• The approach serves as a test for pleiotropy and can inform instrument selection.
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2017), respectively.22 We find evidence suggesting a positive
association between BMI and SBP, and substantial agreement
between MRGxE and two-sample summary MR estimates.
Finally, we conduct a simulation study demonstrating the ef-
fectiveness of the approach under varying conditions.
Methods
Non-technical intuition
Consider a situation in which the instrument–exposure as-
sociation is found to vary between subgroups of the target
population. We follow Slichter in defining an observed
subgroup for which the instrument does not predict the ex-
posure of interest as a no-relevance group.9 As a valid IV
can only be associated with the outcome of interest
through the exposure, it follows that the IV would be inde-
pendent of the outcome for the no-relevance group. An ob-
served non-zero association for the no-relevance group
therefore serves as evidence of pleiotropy.
This intuitive approach has been considered in several
epidemiological studies. For example, Chen et al.19 consid-
ered differences in drinking behaviour by gender in East
Asian populations within a fixed-effects meta-analysis of
the ALDH2 genetic variant and blood pressure. This inter-
action has received further attention in work such as
Taylor et al.23 and Cho et al.14 Previous applications also
extend beyond simple gender differences. For example,
Tyrrell et al. identified genetically predicted BMI as a
weaker instrument for participants experiencing lower lev-
els of socio-economic deprivation, utilizing negative con-
trols to examine residual confounding.16
In presenting MRGxE, we highlight similarities to the ap-
proach of Cho et al.,14 in which a gender–ALDH2 interac-
tion term was incorporated within a TSLS model to estimate
the effect of alcohol consumption. We clarify how it works
when individual-level data are available and crucially demon-
strate how MRGxE extends this approach to summary data.
The MRGxE framework
Consider an MR study consisting of N participants
(indexed by i ¼ 1; . . . ;N). For each participant, we record
observations of a genetic instrument Gi, an exposure Xi,
an outcome Yi and a further covariate Zi, which induces
variation in the association between Gi and Xi through an
interaction GZi. The relationship between each variable is
illustrated in Figure 1, with U representing a set of all
unmeasured variables confounding X and Y, and IGZ rep-
resenting the interaction term.
The exposure X is a linear function of G; Z; GZ; U
and an independent error term, X, whilst the outcome Y
is a linear function of G; Z;GZ; U;X and an independent
error term, Y . Using c and b to denote regression coeffi-
cients for the first- and second-stage models, respectively, a
two-stage model can be defined as:
Xi ¼ c0 þ c1Gi þ c2Zi þ c3GZi þUi þ Xi; (1)
Yi ¼ b0 þ b1Xi þ b2Gi þ b3Zi þ b4GZi þUi þ Yi: (2)
The causal effect of X on Y is denoted by b1 and the
pleiotropic effect of the instrument is b2. Note that
regressing Y upon X would be prone to confounding bias
and applying TSLS would give biased estimates
when b2 6¼ 0. This is demonstrated in the Supplementary
Material, available as Supplementary data at IJE online.
MRGxE adopts a gene–covariate interaction as an in-
strument, subsequently placing restrictions on the interac-
tion analogous to the IV assumptions. A suitable
interaction GZ is therefore:
GxE1: Associated to the exposure of interest (c3 6¼ 0).
GxE2: Not associated with confounders of the exposure
and outcome (GZ?U).
GxE3: Not associated with the outcome outside of the
exposure of interest (b4 ¼ 0).
The first assumption is assessed by directly fitting the
first-stage model. For the second assumption, it is impor-
tant to stress that it pertains to the independence of the in-
teraction with respect to confounders, and not G and Z
individually. The third assumption requires pleiotropic
effects remain constant across the population. Variation in
pleiotropic effects can be driven by violations of the second
assumption, as outlined in the following section.
A value of Z defining a no-relevance group (observed or
hypothetical) can be derived as the covariate value Z ¼ zX
at which G and X are independent, calculating the partial
effect of G upon X and rearranging such that:
Figure 1. A directed acyclic graph (DAG) showing the assumed relation-
ship between each variable in MRGxE.
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dX
dG
¼ c1 þ c3Zi ¼ 0: (3)
This yields the trivial solution
zX ¼  c1c3
 
: (4)
Where zX is observed in the population, regressing Y
upon G for the subset of participants with Z ¼ zX pro-
vides a pleiotropy estimate (that is for b2Þ as the coefficient
of G. Unfortunately, this is difficult to implement in prac-
tice, either because the value zX is not observed or the sub-
set of participants is too small to provide sufficient power.
Consequently, it is often appropriate to estimate pleiotropy
at a theoretical (or extrapolated) no-relevance group, using
differences in instrument–exposure associations across Z.
To illustrate how this is possible, a reduced-form IV
model is constructed—that is, models for X given G,
and Y given G by rewriting Model (1) as
Xi ¼ c0 þ c1 þ c3Zið ÞGi þ c2Zi þUi þ Xi (5)
and Model (2) as
Yi ¼ b0 þ b1ðc1 þ c3ZiÞ þ b2 þ b4Zi þUi þ Xi½ Gi þ b3Zi
þUi þ Yi:
(6)
The change in GX and G Y associations for a
given change in Z can be identified as the coefficient of
G in Models (5) and (6), respectively (with b4 set to 0), as
GX association : ðc1 þ c3ZiÞ;
G Y association : ½b1ðc1 þ c3ZiÞ þ b2:
The Wald ratio24 estimand for the causal effect of X
on Y would then be equal to:
b1 c1 þ c3Zið Þ þ b2
c1 þ c3Zi
¼ b1 þ
b2
c1 þ c3Zi
: (7)
This gives the causal effect, b1, plus a non-zero bias
term whenever b2 is non-zero. In the Cho et al.
14 analysis,
an estimate for b1 was obtained by performing TSLS re-
gression using the interaction as the instrument; fitting
Models (8) and (9) below:
Xi ¼ c1 þ c3Zið ÞGi þ c2Zi þ Xi; (8)
Yi ¼ b0 þ b1X^i þ b2Gi þ b3Zi þ Yi; (9)
where X^i is the fitted value from Model (8). In this case,
the coefficient b2 represents the degree of pleiotropy for
the genetic instrument G.
Whilst this approach does not require an observed
no-relevance group, it has two limitations. First, as a
consequence of utilizing TSLS, it is restricted to individ-
ual-level data. Second, it assumes an underlying linear
model, which may not hold in practice. For example, if
considering adiposity as an exposure, individuals at ex-
treme values could be at greater risk, implying a curved
relationship.
MRGxE overcomes these limitations by reframing the
model within a two-sample summary MR context, and ex-
ecuting the following three-step procedure:
1. Estimate GX and G Y associations at a range of
values of Z.
2. Regress the G Y associations on the GX associa-
tions within a linear regression.
3. Estimate the causal effect b1 as the slope of the regres-
sion, and the mean pleiotropic effect as the intercept of
the regression.
Let Zj denote the j
th subgroup of Z (j ¼ 1; . . . ; JÞ. For
each group Zj, we estimate the instrument–exposure asso-
ciation and standard error (Step 1) using the following re-
gression model:
Xi ¼ cj0 þ cj1Gi þ jXi: (10)
Note that we include a subscript j to distinguish the re-
gression parameters from the first-stage Model (1). The co-
efficient cj1 is therefore interpreted as the GX
association for group Zj. Next, we fit the corresponding
instrument–outcome regression model (Step 2):
Yi ¼ d0j þ dj1Gi þ jYi: (11)
We use dj1 to denote the G Y association coefficient
for group Zj, distinguishing Model (11) from Model (6).
Thus, from Models (10) and (11), we obtain sets of GX
associations ðc^J1Þ and G Y associations ðd^J1Þ across ZJ
subgroups. Finally, we regress the set of d^J1 estimates upon
the set of c^J1 estimates (Step 3):
d^J1 ¼ bGxE0 þ bGxE1c^J1 þ JGxE: (12)
In Model (12), bGxE0 is the pleiotropy estimate ðb2Þ,
whilst bGxE1 is the effect of X upon Y correcting for plei-
otropy (b1). To illustrate, recall that b2 represents a con-
stant pleiotropic effect across Z. Model (12) is an average
of the ratio estimates across ZJ, with the bias parameter b2
estimated as the intercept. A diagram illustrating these fea-
tures is given in the Supplementary Material, available as
Supplementary data at IJE online, accompanied by a dem-
onstration of how the functional form of the interaction
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can be inferred from the distribution of the subgroup
estimates.
To show how the intercept estimates b2, consider the
reduced-form Model (6) evaluated for the no-relevance
group Z ¼ zX. From Equation (4), zX ¼  c1c3
 
. Then, by
substitution:
b1c1 þ b1c3
c1
c3
 
þ b2 ¼ b1c1  b1c1 þ b2 ¼ b2: (13)
Where the intercept is zero, the MRGxE causal-effect
estimate is identical to an IVW estimate using the subgroup
ratio estimates. This mirrors the equivalence of IVW and
MR-Egger regression in the multiple instrument setting
with balanced pleiotropy. R code for implementing
MRGxE is provided in the Supplementary Material, avail-
able as Supplementary data at IJE online.
Before continuing, it is important to highlight several
important factors to consider when implementing
MRGxE. Initially, it is important to define an appropriate
number of Z subgroups so as to accurately characterize the
underlying gene–covariate interaction. Second, it is impor-
tant to not transform effects to be positive, as performed
for MR-Egger regression. This mischaracterizes the inter-
action term, attenuating causal-effect estimates. Finally,
where instrument–exposure associations are present for all
groups in the same direction, the accuracy in extrapolating
the regression line towards a theoretical no-relevance
group will be a function of the distance from the minimum
Zj instrument–exposure association and variation in the
set of Zj instrument–exposure associations. Further guid-
ance and illustrations of these features of MRGxE are
presented in the Supplementary Material, available as
Supplementary data at IJE online.
The constant-pleiotropy assumption
As a single (constant) parameter, b2 equates to the ‘cor-
rect’ intercept for MRGxE—that is, the intercept that must
be estimated in order to identify the correct causal effect
b1: Consistent estimates for both b1 and b2 are produced
in cases where the pleiotropic effect remains constant
across all values of Z ( b4 ¼ 0). If b4 6¼ 0, then the con-
stant-pleiotropy assumption is violated, leading to the true
pleiotropic effect b2 being equated to b2  b4c1c3 and bias in
the causal estimand for b1 such that:
b^1 ¼ b1 þ
b4
c3
: (14)
The derivation of this result is provided in the
Supplementary Material, available as Supplementary data
at IJE online. From Equation (14), it is clearly possible to
mitigate such bias when the instrument–covariate inter-
action ðc3Þ is large relative to the variation in the pleiotro-
pic effect b4, with the bias tending towards zero
as c3 increases. However, as it is not possible to directly es-
timate b4, justifying the relative effect sizes of the first- and
second-stage interactions requires a priori knowledge.
Violations of the constant-pleiotropy assumption can
result from specific confounding structures in the underly-
ing true model. Specifically, there must be no downstream
pathway from G to Z via the confounders U, no pathway
from Z to G through U, and U cannot be a joint determi-
nant of G and Z. Figure 2 shows four possible scenarios in
which G and Z are associated with U:
In Figure 2, Scenarios (a), (b) and (d) introduce bias in
MRGxE estimates, whilst Scenario (c) and individual associa-
tions between either Z and G with U do not. Further details
on the underlying mechanisms behind such bias are presented
in the Supplementary Material, available as Supplementary
data at IJE online. As a consequence, the range of interaction
covariates suitable for use within MRGxE is not as restrictive
as one might naively assume. In an MR context, there are
limited cases in which a confounder will be a determinant of
a genetic instrument, and this is only problematic where the
confounder is simultaneously associated with the interaction
covariate. It seems that MRGxE estimates will be most sus-
ceptible to bias where the instrument is a determinant of one
or more confounders, which in turn are determinants of the
interaction covariate. We recommend care be taken in exam-
ining such pathways and suggest MRGxE be implemented as
one component of a series of sensitivity analyses, as with
other such approaches.4
MRGxE as a sensitivity analysis
In cases where the constant-pleiotropy assumption is as-
sumed to be violated, MRGxE can still be applied in sensi-
tivity analyses to select a subset of valid instruments. To
demonstrate, consider that an invalid instrument can be
detected, in principle whenever b2  b4c1c3 6¼ 0, due to
either b2 6¼ 0, b4 6¼ 0 or both. Consequently, MRGxE can
be used to assess the validity of individual instruments,
informing instrument selection and evaluating the appro-
priateness of their incorporation in allelic scores. There
are, however, two important considerations when applying
this approach. First, it is not possible to distinguish the av-
erage pleiotropic effect across interaction-covariate sub-
groups (b2) from the change in pleiotropic effect between
instrument–covariate subgroups b4ð Þ. It is therefore a test
of invalidity due to either factor and cannot be used to cor-
rect MRGxE estimates directly. Second, MRGxE will
International Journal of Epidemiology, 2018, Vol. 0, No. 0 5
D
ow
nloaded from
 https://academ
ic.oup.com
/ije/advance-article-abstract/doi/10.1093/ije/dyy204/5193695 by U
niversity Library user on 21 January 2019
incorrectly fail to detect invalid instruments (a Type II er-
ror) in the special case where b2 is close to  b4c1c3
 
.
Causal effect of BMI upon SBP
Previous observational,25 randomized control trials26 and
MR27–29 studies have reported evidence of a positive asso-
ciation between BMI and SBP. However, the magnitude of
this association differs markedly between such studies,
with observational studies often recording greater effect
sizes than those using MR.
As an applied example, we perform two-sample sum-
mary MR and MRGxE analyses examining the effect of
BMI upon SBP using variants identified from the GIANT
consortium22 and two non-overlapping random samples of
UK Biobank. The decision to use two subsamples of the
UK Biobank, as opposed to summary estimates from the
GIANT consortium, is motivated by potential differences
in the standardization of BMI between each sample. As
MRGxE utilizes BMI values from the UK Biobank,
selecting two subsamples for which BMI has been identi-
cally standardized allows a more effective comparison of
the approaches.
The purpose of performing both two-sample summary
and MRGxE analyses is to highlight the extent to which
pleiotropic effect estimates obtained using MRGxE with
a single instrument agree with conventional MR
approaches. Initially, the UK Biobank sample contained a
total of 502 614 individuals. From this sample, we ex-
cluded participants who failed to meet quality control,
specifically in cases where genetic and reported sex con-
flicted, where sex chromosome karyotypes were puta-
tively different from XX and XY, and individuals who
were outliers with respect to heterozygosity and missing
rates. Further, we removed participants of non-European
ancestry and related individuals by preferentially remov-
ing individuals related to the greatest number of individu-
als until no related pairs remained. This resulted in
a total of 358 928 participants being included in the
analyses.
(a) (b)
(c) (d)
Figure 2. A set of DAGs illustrating interaction-covariate confounding structures indicated by dashed lines. Scenarios (a), (b) and (d) induce bias in
MRGxE estimates. However, this is not the case for Scenario (c) or when the confounder is associated with either G or Z individually.
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In conducting a two-sample summary analysis, effect
estimates and standard errors for 96 genetic variants iden-
tified by the GIANT consortium as being robustly associ-
ated with BMI ðp ¼ 5  108Þ were obtained from a 50%
random sample of the UK Biobank.22 Corresponding esti-
mates for each genetic variant with respect to SBP were
obtained using the remaining UK Biobank sample. In con-
trast, MRGxE was implemented by constructing a
weighted allelic score informed using estimates from the
GIANT consortium. The MRGxE analysis can be viewed
as analogous to two-sample summary MR, using instru-
ment–exposure estimates for BMI as external weights and
individual data from a separate sample to inform instru-
ment–outcome association estimates. In each analysis,
BMI, SBP and the weighted allelic score were standardized
using a z-score transformation.
Two-sample summary analyses
We implement several two-sample summary MR methods
utilizing the mrrobust software package30 in Stata SE
14.0.31 IVW provides estimates with greater precision than
alternative summary approaches; however, as such esti-
mates can exhibit bias in the presence of pleiotropy, MR-
Egger regression, weighted median and weighted modal
approaches are implemented as sensitivity analyses.
A range of methods are adopted in sensitivity analyses,
as each method relies upon differing assumptions with re-
spect to the underlying distribution of pleiotropic effects.
MR-Egger regression requires the effect of genetic variants
on the exposure to be independent of their pleiotropic
effects on the outcome (InSIDE).5 The weighted median
requires more than 50% of the variants to be valid instru-
ments accounting for weighting,7 whilst the modal estima-
tor assumes that the most frequent value of the pleiotropic
bias across the set of genetic variants is zero (ZEMPA).32
MRGxE analyses using Townsend Deprivation
Index
In implementing MRGxE, Townsend Deprivation Index
(TDI) was selected as a continuous covariate for which in-
strument strength varies, based on findings from previous
studies.16,33 TDI is a common derived measure of socio-
economic deprivation, using many variables such as car
ownership, occupation type and educational attainment.34
It is measured at an area level (electoral wards), with par-
ticipants assigned a score based upon the area in which
they lived.34 Missing values were removed prior to per-
forming the analysis, with observational and TSLS esti-
mates presented in the Supplementary Material, available
as Supplementary data at IJE online.
Simulation overview
To illustrate the effectiveness of MRGxE, and further con-
sider the importance of the constant-pleiotropy assumption
with respect to causal-effect estimation, we performed a
simulation study within a two-sample MR framework.
Considering a realistic case, two sets of simulations were
performed, the first using a null causal effect ðb1 ¼ 0) and
indexed as A, and the second a positive causal
effect ðb1 ¼ 0:05) indexed as B. Individual-level data are
generated, from which the necessary summary-data esti-
mates are extracted. In each case, a total of 5 population
subgroups are used from a sample size of 50 000, with fur-
ther details provided in the Supplementary Material, avail-
able as Supplementary data at IJE online.
Four distinct cases were considered:
Case 1: No pleiotropy and the constant-pleiotropy as-
sumption satisfied
Case 2: Directional pleiotropy and the constant-pleiot-
ropy assumption satisfied
Case 3: No pleiotropy and the constant-pleiotropy as-
sumption violated
Case 4: Directional pleiotropy and the constant-pleiot-
ropy assumption violated
The results for each case represent the mean values for
10 000 simulated datasets.
Results
Analysis I: two-sample summary analysis
Estimates obtained from implementing each two-sample
summary MR approach are presented in Table 1. All of the
methods performed with the exception of SIMEX-
corrected MR-Egger show evidence of a positive associa-
tion between BMI and SBP. There also appears limited
evidence of a pleiotropic effect, with the IVW estimate ly-
ing within the confidence intervals of both the weighted
median and weighted modal estimates.
Analysis II: MRGxE using TDI
To perform MRGxE, we divided the sample using quan-
tiles of TDI into 5, 10, 20 and 50 population subgroups,
after which IVW and MRGxE estimates were produced.
The results of each analysis are presented in Table 2, with
IVW referring to an inverse-variance-weighted estimate us-
ing interaction-covariate subgroups.
The estimates in Table 2 largely agree with the two-
sample summary MR estimates in several aspects, with the
direction of effect remaining consistent across each of the
methods applied. This again implies a positive effect of
BMI upon SBP. Considering the MR-Egger and MRGxE
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intercept estimates, there also appears to be little
evidence of substantial pleiotropic bias. Constraining the
MRGxE model to the intercept yields an estimate
equivalent to the two-sample summary IVW estimate pre-
sented in Table 1.
Notably, whilst the MR-Egger estimates are consistent
with the MRGxE estimates, the effects are markedly differ-
ent, with MRGxE returning a positive point estimate
greater in magnitude than the IVW estimate. The differ-
ence in these estimates can be attributed to the differing in-
tercept estimates that, while close to zero in both cases, are
different in terms of direction. As the MR-Egger and
MRGxE intercept estimates lie within their overlapping
confidence intervals, we would highlight this as a case
where the discrepancy may be due to a lack of precision. In
this case, it could be argued to be appropriate to conclude
that there is a lack of robustly identified directional pleio-
tropic effect and adopt the IVW estimate.
Figure 3 displays both the IVW and MRGxE estimates
for the five-group case, whilst corresponding plots for
other groups are presented in the Supplementary Material,
available as Supplementary data at IJE online.
Considering Figure 3, the ordering of the TDI groups
supports the assumption that the instrument–exposure as-
sociation varies across levels of TDI. In particular, the least
deprived groups (Group 1 and Group 2) have the weakest
association, suggesting that genetically predicted BMI is a
weaker predictor of BMI for participants experiencing
lower levels of deprivation. A further observation is that
the positioning of each estimate provides some evidence of
a linear interaction, with instrument strength increasing
monotonically as subgroup TDI increases. However, the
close proximity of Groups 1 and 2, as well as Groups 3
and 4, could be indicative of non-linearity, as they could
represent inflection points in the underlying distribution of
the interaction (see the Supplementary Material, available
as Supplementary data at IJE online, for inference
guidelines).
One important consideration in performing MR analyses
is that causal-effect estimates are often uncertain, due to
Table 1. Two-sample summary MR estimates for the effect of body mass index (BMI) upon systolic blood pressure (SBP). A
smoothing parameter (/ ¼ 1) was selected in implementing the modal estimator and a value I2GX ¼ 0:89 using MR-Egger is in-
dicative of regression dilution of approximately 11% towards the null
Method Estimate SE 95% CI p-value
IVW 0.101 0.031 (0.04, 0.16) 0.001
MR-Egger (intercept)
MR-Egger (effect)a
0.002
0.027
0.001
0.062
(–0.001, 0.005)
(–0.09, 0.15)
0.173
0.658
SIMEX-corrected MR-Egger (intercept)
SIMEX-corrected MR-Egger (effect)
0.003
–0.020
0.003
0.154
(–0.003, 0.01)
(–0.32, 0.28)
0.898
0.325
Weighted median 0.147 0.032 (0.08, 0.21) <0.001
Modal estimatorb 0.102 0.031 (0.04, 0.16) 0.001
aI2GX ¼ 0:90
bSmoothing parameter / ¼ 1.
Table 2. Inverse-variance-weighted (IVW) and MRGxE estimates for different numbers of Townsend Deprivation Index (TDI)
quantile groupings. The IVW estimate represents an inverse weighted estimate using each of the TDI subgroups, providing an
estimate equivalent to two-stage least-squares estimates using the weighted allelic score
Number of groups Method Estimate SE 95% CI p-value
MRGxE (intercept) –0.007 0.007 (–0.03, 0.02) 0.383
5 MRGxE (effect) 0.161 0.054 (–0.01, 0.33) 0.059
IVW 0.106 0.008 (0.08, 0.13) 0.0002
MRGxE (intercept) –0.009 0.009 (–0.03, 0.01) 0.347
10 MRGxE (effect) 0.169 0.064 (0.02, 0.32) 0.030
IVW 0.106 0.010 (0.08, 0.13) <0.0001
MRGxE (intercept) –0.005 0.012 (–0.03, 0.02) 0.669
20 MRGxE (effect) 0.144 0.088 (–0.04, 0.33) 0.121
IVW 0.106 0.013 (0.08, 0.13) <0.0001
MRGxE (intercept) –0.007 0.011 (–0.03, 0.01) 0.517
50 MRGxE (effect) 0.157 0.078 (0.000, 0.31) 0.049
IVW 0.107 0.013 (0.08, 0.13) <0.0001
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either a lack of precision or doubts regarding the assumptions
of the approach. One response put forward by VanderWeele
et al.35 has been to shift the emphasis from identifying the
magnitude of causal effects to identifying the presence of
causal effects. Under such a paradigm, estimation using in-
strument–covariate interactions, such as through MRGxE,
can be insightful in identifying broad effects or associations.
Adopting this rationale, MRGxE can be used as a broad test
of instrument validity in cases where the underlying assump-
tions of the approach are likely violated, focusing on effect di-
rection as opposed to effect magnitude.
Simulations
Results of the simulation analyses are presented in Table 3.
The mean F statistic remains the same for each case, with
substantial variation in the F statistic between interaction-
covariate groups. This is essential, as the variation in
instrument strength is representative of variation in instru-
ment relevance across population subgroups. Estimates us-
ing IVW and MRGxE, as well as significance values, were
taken directly from each regression output without using
regression weights, as the variant–outcome associations
have the same standard errors.
In the valid instrument case, both IVW and MRGxE
provide unbiased effect estimates, though the IVW esti-
mate is more accurate. This is similar to comparisons be-
tween IVW and MR-Egger regression, supporting use of
IVW in cases where pleiotropy is absent. Type I error rates
remained at approximately 5% for both IVW and
MRGxE. In the second case, IVW exhibits bias, whilst
MRGxE continues to produce unbiased estimates.
In the third case, the instrument is not valid, but pleiotro-
pic effects change across population subgroups. Here, both
IVW and MRGxE produce biased causal-effect estimates,
with the MRGxE effect estimates showing a greater degree
of bias than the IVW estimates. This increases the Type I er-
ror rate relative to IVW. In this situation, the MRGxE test
for pleiotropy is particularly powerful, though this seeming
increase in power can be attributed to violation of the con-
stant-pleiotropy assumption b4 6¼ 0ð Þ leading to over-esti-
mation of the magnitude of the pleiotropic effects. In the
final case, both IVW and MRGxE produce estimates with
similar bias and precision. Here, the MRGxE test for pleiot-
ropy is suggestive of a null pleiotropic effect, remaining at
5%. This represents a situation in which b2 ¼ b4, invalidat-
ing the use of MRGxE as a sensitivity analysis.
Discussion
In this paper, we present MRGxE as a simple and intuitive
method to identify and correct for pleiotropic bias in MR
studies using instrument–covariate interactions. MRGxE
enables the pleiotropic effect of individual instruments (or
single allele scores) to be assessed and, when such pleiot-
ropy exists and satisfies the constant-pleiotropy assump-
tion, MRGxE provides improved causal estimation
compared with IVW. In the absence of such pleiotropy, the
IVW approach is more accurate and should be preferred.
In cases where the constant-pleiotropy assumption is vi-
olated, a sensible approach would be to prune invalid var-
iants using pleiotropy estimates from MRGxE and then
implement IVW using valid variants. In this sense, MRGxE
can be viewed very much as a tool for sensitivity analysis.
Two-sample summary MRGxE
Whilst this paper has focused on the application of
MRGxE to individual-level data (albeit by extracting and
then meta-analysing summary statistics obtained from it),
it clearly applies where interaction–subgroup-specific sum-
mary data on instrument–exposure and instrument–out-
come associations are available. An alternative approach
would be to meta-analyse summary statistics obtained
from many separate studies under the assumption that
study-specific estimates relate to a study-specific character-
istic. For example, the work of Robinson et al.36 highlights
the interaction between age and adult BMI heritability as
one potential candidate, given that age is likely to vary nat-
urally across contributing studies.
Figure 3. A scatterplot showing the MRGxE estimate indicated as a
dashed line. Each point represents ascending quintiles of the Townsend
Deprivation Index, in this case showing the strength of the instrument–
exposure association to increase with increasing socio-economic
deprivation.
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Limitations of MRGxE
A number of factors must be considered before implement-
ing MRGxE. First, the constant-pleiotropy assumption is
essential for causal estimate correction. If there is reason to
believe that pleiotropic effects differ between population
subgroups, then the approach will give misleading effect
estimates. One useful aspect to this problem, however, is
that, provided the first-stage interaction is sufficiently
strong, bias from changes in pleiotropic effect may be suffi-
ciently small as to be negligible in analyses. This may well
be the case in situations such as the Cho et al.14 study,
where the difference in instrument effect between gender
groups is very strong in comparison to potential variation
in pleiotropic effect. In our analyses, the use of an allele
score as a single (strong) instrument meant that it was nat-
urally much more robust to bias than any individual com-
ponent SNP. One strategy to overcome this limitation
would be to carry out several analyses using differing inter-
action covariates. Provided that the instrument–covariate
interaction of sufficient strength, it would be expected that
resulting estimates would be in agreement. In cases where
substantial disagreement is observed, such disagreement
could be indicative of violation of the constant-pleiotropy
assumption or characteristics of the underlying confound-
ing structure. The work of Emdin et al.15 and Krishna
et al.37 follows this reasoning. Further work will consider
the implications of interaction-covariate selection and the
role of confounding within the context of MRGxE.
A second limitation is that, owing to the limited avail-
ability of summary-data estimates for particular covariate
groups, it may be difficult to implement in a summary-data
setting. At present, researchers may be limited to common
groupings such as gender.
Finally, it is important to consider results from MR
gene–environment interaction approaches within the
context of existing evidence using alternate estimation
approaches, within the triangulation framework38,39 in
which differences in estimates across a range of approaches
can be indicative of sources of bias potentially unique to
each research design. Identifying disagreement in estimated
effects across studies of differing design can therefore
prove valuable in identifying avenues for further research,
whilst substantial agreement strengthens confidence in the
resulting findings and subsequent inference.
Supplementary data
Supplementary data are available at IJE online.
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